656 related articles for article (PubMed ID: 10491534)
21. IL-22, but not IL-17, dominant environment in cutaneous T-cell lymphoma.
Miyagaki T; Sugaya M; Suga H; Kamata M; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
Clin Cancer Res; 2011 Dec; 17(24):7529-38. PubMed ID: 22048239
[TBL] [Abstract][Full Text] [Related]
22. Telomere stability is frequently impaired in high-risk groups of patients with myelodysplastic syndromes.
Ohyashiki JH; Iwama H; Yahata N; Ando K; Hayashi S; Shay JW; Ohyashiki K
Clin Cancer Res; 1999 May; 5(5):1155-60. PubMed ID: 10353751
[TBL] [Abstract][Full Text] [Related]
23. Telomerase activity in neuroendocrine tumors.
Bockhorn M; Frilling A; Clauer U; Hertl M; Broelsch CE
Int J Surg Investig; 2000; 2(3):219-25. PubMed ID: 12678522
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of IkappaB kinase subunit 2 in cutaneous T-cell lymphoma down-regulates nuclear factor-kappaB constitutive activation, induces cell death, and potentiates the apoptotic response to antineoplastic chemotherapeutic agents.
Sors A; Jean-Louis F; Bégué E; Parmentier L; Dubertret L; Dreano M; Courtois G; Bachelez H; Michel L
Clin Cancer Res; 2008 Feb; 14(3):901-11. PubMed ID: 18245554
[TBL] [Abstract][Full Text] [Related]
25. Clonal T cell receptor gamma-chain gene rearrangement by PCR-based GeneScan analysis in the skin and blood of patients with parapsoriasis and early-stage mycosis fungoides.
Klemke CD; Dippel E; Dembinski A; Pönitz N; Assaf C; Hummel M; Stein H; Goerdt S
J Pathol; 2002 Jul; 197(3):348-54. PubMed ID: 12115881
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of telomerase activity in cutaneous melanocytic proliferations.
Miracco C; Pacenti L; Santopietro R; Laurini L; Biagioli M; Luzi P
Hum Pathol; 2000 Sep; 31(9):1018-21. PubMed ID: 11014565
[TBL] [Abstract][Full Text] [Related]
27. Telomerase functions beyond telomere maintenance in primary cutaneous T-cell lymphoma.
Chevret E; Andrique L; Prochazkova-Carlotti M; Ferrer J; Cappellen D; Laharanne E; Idrissi Y; Boettiger A; Sahraoui W; Ruiz F; Pham-Ledard A; Vergier B; Belloc F; Dubus P; Beylot-Barry M; Merlio JP
Blood; 2014 Mar; 123(12):1850-9. PubMed ID: 24470590
[TBL] [Abstract][Full Text] [Related]
28. Telomerase activity in prognostic histopathologic features of melanoma.
Carvalho L; Lipay M; Belfort F; Santos I; Andrade J; Haddad A; Brunstein F; Ferreira L
J Plast Reconstr Aesthet Surg; 2006; 59(9):961-8. PubMed ID: 16920589
[TBL] [Abstract][Full Text] [Related]
29. Telomerase activity in head and neck squamous cell carcinoma and adjacent tissues.
Mao L; El-Naggar AK; Fan YH; Lee JS; Lippman SM; Kayser S; Lotan R; Hong WK
Cancer Res; 1996 Dec; 56(24):5600-4. PubMed ID: 8971162
[TBL] [Abstract][Full Text] [Related]
30. Expression of telomeric repeat binding factor 1 and 2 and TRF1-interacting nuclear protein 2 in human gastric carcinomas.
Matsutani N; Yokozaki H; Tahara E; Tahara H; Kuniyasu H; Haruma K; Chayama K; Yasui W; Tahara E
Int J Oncol; 2001 Sep; 19(3):507-12. PubMed ID: 11494028
[TBL] [Abstract][Full Text] [Related]
31. [Correlations of telomere length and telomerase activity to radiosensitivity of human laryngeal squamous carcinoma cells].
Xiao CY; Zhou FX; Liu SQ; Xie CH; Dai J; Zhou YF
Ai Zheng; 2005 Jun; 24(6):653-6. PubMed ID: 15946472
[TBL] [Abstract][Full Text] [Related]
32. Telomerase activity in giant cell tumors of bone.
Matsuo T; Hiyama E; Sugita T; Shimose S; Kubo T; Mochizuki Y; Adachi N; Kojima K; Sharman P; Ochi M
Ann Surg Oncol; 2007 Oct; 14(10):2896-902. PubMed ID: 17653593
[TBL] [Abstract][Full Text] [Related]
33. Telomere shortening and decreased replicative potential, contrasted by continued proliferation of telomerase-positive CD8+CD28(lo) T cells in patients with systemic lupus erythematosus.
Honda M; Mengesha E; Albano S; Nichols WS; Wallace DJ; Metzger A; Klinenberg JR; Linker-Israeli M
Clin Immunol; 2001 May; 99(2):211-221. PubMed ID: 11318593
[TBL] [Abstract][Full Text] [Related]
34. The relationship between telomere length and telomerase activity in gynecologic cancers.
Wang SJ; Sakamoto T; Yasuda Si S; Fukasawa I; Ota Y; Hayashi M; Okura T; Zheng JH; Inaba N
Gynecol Oncol; 2002 Jan; 84(1):81-4. PubMed ID: 11748981
[TBL] [Abstract][Full Text] [Related]
35. Telomere dynamics in cells with introduced telomerase: a rapid assay for telomerase activity on telomeres.
McChesney PA; Aisner DL; Frank BC; Wright WE; Shay JW
Mol Cell Biol Res Commun; 2000 May; 3(5):312-8. PubMed ID: 10964756
[TBL] [Abstract][Full Text] [Related]
36. Analysis of telomerase activity and telomere function in cancer.
Gordon KE; Parkinson EK
Methods Mol Biol; 2004; 281():333-48. PubMed ID: 15220541
[TBL] [Abstract][Full Text] [Related]
37. Correlation between telomerase expression and terminal restriction fragment length ratio in non-small cell lung cancer--an adjusted measurement and its clinical significance.
Hsu CP; Miaw J; Shai SE; Chen CY
Eur J Cardiothorac Surg; 2004 Aug; 26(2):425-31. PubMed ID: 15296909
[TBL] [Abstract][Full Text] [Related]
38. Clinical implications of telomerase activity levels in acute leukemia.
Ohyashiki JH; Ohyashiki K; Iwama H; Hayashi S; Toyama K; Shay JW
Clin Cancer Res; 1997 Apr; 3(4):619-25. PubMed ID: 9815729
[TBL] [Abstract][Full Text] [Related]
39. Telomere length, telomerase activity and telomerase RNA expression in human esophageal cancer cells: correlation with cell proliferation, differentiation and chemosensitivity to anticancer drugs.
Asai A; Kiyozuka Y; Yoshida R; Fujii T; Hioki K; Tsubura A
Anticancer Res; 1998; 18(3A):1465-72. PubMed ID: 9673357
[TBL] [Abstract][Full Text] [Related]
40. Telomere attrition and telomerase activity are associated with GSTM1 polymorphism in oral cancer.
Sainger RN; Shah FD; Telang SD; Shah PM; Patel PS
Cancer Biomark; 2009; 5(4):189-95. PubMed ID: 19729828
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
